Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Carsten Schröter"'
Autor:
Katharina Linse, Constanze Weber, Peter Reilich, Florian Schöberl, Matthias Boentert, Susanne Petri, Annekathrin Rödiger, Andreas Posa, Markus Otto, Joachim Wolf, Daniel Zeller, Robert Brunkhorst, Jan Koch, Andreas Hermann, Julian Großkreutz, Carsten Schröter, Martin Groß, Paul Lingor, Gerrit Machetanz, Luisa Semmler, Johannes Dorst, Dorothée Lulé, Albert Ludolph, Thomas Meyer, André Maier, Moritz Metelmann, Martin Regensburger, Jürgen Winkler, Berthold Schrank, Zacharias Kohl, Tim Hagenacker, Svenja Brakemeier, Ute Weyen, Markus Weiler, Stefan Lorenzl, Sarah Bublitz, Patrick Weydt, Torsten Grehl, Sylvia Kotterba, Hanna-Sophie Lapp, Maren Freigang, Maximilian Vidovic, Elisa Aust, René Günther
Publikováno v:
Neurological Research and Practice, Vol 6, Iss 1, Pp 1-8 (2024)
Abstract Introduction Amyotrophic lateral sclerosis (ALS) is an inevitably fatal condition that leads to a progressive loss of physical functioning, which results in a high psychosocial burden and organizational challenges related to medical care. Mu
Externí odkaz:
https://doaj.org/article/c0f478ca254b44ff867cfc78aad679ea
Publikováno v:
Neurological Research and Practice, Vol 5, Iss 1, Pp 1-11 (2023)
Abstract Background Causal therapies are not yet available for most neuromuscular diseases. Additionally, data on the use of complementary or alternative therapies (CAM) in patients groups with a variety of different neuromuscular diseases are rare.
Externí odkaz:
https://doaj.org/article/ba9d85b0659e443cbd888a33dd5d71ff
Autor:
Pavel Schischlevskij, Isabell Cordts, René Günther, Benjamin Stolte, Daniel Zeller, Carsten Schröter, Ute Weyen, Martin Regensburger, Joachim Wolf, Ilka Schneider, Andreas Hermann, Moritz Metelmann, Zacharias Kohl, Ralf A. Linker, Jan Christoph Koch, Claudia Stendel, Lars H. Müschen, Alma Osmanovic, Camilla Binz, Thomas Klopstock, Johannes Dorst, Albert C. Ludolph, Matthias Boentert, Tim Hagenacker, Marcus Deschauer, Paul Lingor, Susanne Petri, Olivia Schreiber-Katz
Publikováno v:
Brain Sciences, Vol 11, Iss 6, p 748 (2021)
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that causes progressive autonomy loss and need for care. This does not only affect patients themselves, but also the patients’ informal caregivers (CGs) in their health, perso
Externí odkaz:
https://doaj.org/article/97ac8e0413094a19b6607ae2bbfe92c6
Autor:
Tara Peseschkian, Isabell Cordts, René Günther, Benjamin Stolte, Daniel Zeller, Carsten Schröter, Ute Weyen, Martin Regensburger, Joachim Wolf, Ilka Schneider, Andreas Hermann, Moritz Metelmann, Zacharias Kohl, Ralf A. Linker, Jan Christoph Koch, Boriana Büchner, Ulrike Weiland, Erik Schönfelder, Felix Heinrich, Alma Osmanovic, Thomas Klopstock, Johannes Dorst, Albert C. Ludolph, Matthias Boentert, Tim Hagenacker, Marcus Deschauer, Paul Lingor, Susanne Petri, Olivia Schreiber-Katz
Publikováno v:
Brain Sciences, Vol 11, Iss 3, p 372 (2021)
Improving quality of life (QoL) is central to amyotrophic lateral sclerosis (ALS) treatment. This Germany-wide, multicenter cross-sectional study analyses the impact of different symptom-specific treatments and ALS variants on QoL. Health-related QoL
Externí odkaz:
https://doaj.org/article/fdc18fe43d044d80b6d0439741861dc2
Autor:
Albert C. Ludolph, Pavel Schischlevskij, Daniel Zeller, Martin Regensburger, Tim Hagenacker, Claudia Stendel, Ute Weyen, Thomas Klopstock, Benjamin Stolte, Ilka Schneider, Camilla Binz, Olivia Schreiber-Katz, Moritz Metelmann, Zacharias Kohl, Marcus Deschauer, Andreas Hermann, Joachim Wolf, Susanne Petri, Jan C. Koch, Matthias Boentert, Johannes Dorst, René Günther, Isabell Cordts, Paul Lingor, Ralf A. Linker, Alma Osmanovic, Lars H. Müschen, Carsten Schröter
Publikováno v:
Brain Sciences; Volume 11; Issue 6; Pages: 748
Brain Sciences 11(6), 748-(2021). doi:10.3390/brainsci11060748
Brain Sciences, Vol 11, Iss 748, p 748 (2021)
Brain Sciences
Brain Sciences 11(6), 748-(2021). doi:10.3390/brainsci11060748
Brain Sciences, Vol 11, Iss 748, p 748 (2021)
Brain Sciences
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that causes progressive autonomy loss and need for care. This does not only affect patients themselves, but also the patients’ informal caregivers (CGs) in their health, perso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23f15d5e215193127219c0c7dba04fdf
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/16745
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/16745
Autor:
Moritz Metelmann, Tara Peseschkian, Jan C. Koch, Felix Heinrich, Ilka Schneider, Matthias Boentert, Ralf A. Linker, Albert C. Ludolph, Andreas Hermann, Thomas Klopstock, Benjamin Stolte, Martin Regensburger, Marcus Deschauer, Johannes Dorst, Tim Hagenacker, Olivia Schreiber-Katz, Susanne Petri, Erik Schönfelder, Carsten Schröter, Ute Weyen, Zacharias Kohl, Ulrike Weiland, Paul Lingor, René Günther, Alma Osmanovic, Boriana Büchner, Joachim Wolf, Isabell Cordts, Daniel Zeller
Publikováno v:
Brain Sciences
Volume 11
Issue 3
Brain Sciences, Vol 11, Iss 372, p 372 (2021)
Brain Sciences 11(3), 372-(2021). doi:10.3390/brainsci11030372
Volume 11
Issue 3
Brain Sciences, Vol 11, Iss 372, p 372 (2021)
Brain Sciences 11(3), 372-(2021). doi:10.3390/brainsci11030372
Improving quality of life (QoL) is central to amyotrophic lateral sclerosis (ALS) treatment. This Germany-wide, multicenter cross-sectional study analyses the impact of different symptom-specific treatments and ALS variants on QoL. Health-related QoL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74e09d1ba7a0839793f4ff332e33142d